CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Immunic AG

For profitWebsite ↗

Also known as: Immunic AG | Immunic Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 12, 2022

Timeline

2010s

Apr 1, 2016
Immunic AG— Founded

Drugs by trial phase (3 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

Vidofludimus

Phase 2 (1 own, 0 via acquisition)

oseltamivir

Phase 1 (1 own, 0 via acquisition)

imu-935

Indications

Studied for

Recent trials (10)

NCT05201638Lead sponsorPhase 3Jan 12, 2022
NCT05124795Lead sponsorPhase 1Dec 31, 2021
NCT05134441Lead sponsorPhase 3Nov 30, 2021
NCT05054140Lead sponsorPhase 2Sep 30, 2021
NCT04516915CollaboratorPhase 2Jun 15, 2020
NCT04379271Lead sponsorPhase 2/Phase 3May 31, 2020
NCT03846219Lead sponsorPhase 2Jan 28, 2019
NCT03846219Study directorPhase 2Jan 28, 2019
NCT03341962Lead sponsorPhase 2Mar 15, 2018
NCT03341962Study directorPhase 2Mar 15, 2018

Details

Founded: Martinsried, DE Apr 1, 2016
Last known activity: Jan 12, 2022